Skip to main content
. 2023 Jan 17;11(1):e005940. doi: 10.1136/jitc-2022-005940

Table 1.

Comparison of the degrees of tumor-cell killing, enhancement of immune response (in vitro and/or in vivo), toxicity in vivo, and suppression of T cell proliferation among seven commercially available statin drugs

Drug Tumor-cell killing Enhancement of immune response Toxicity in vivo Suppression of T cell proliferation
Lovastatin ++ ++ +
Simvastatin ++ ++ ++
Fluvastatin +++ + ++ N/A
Pitavastatin +++ ++ N/A
Atorvastatin + N/A N/A
Rosuvastatin + N/A N/A
Pravastatin + + N/A N/A

Factors designated as not applicable were not tested.

+++, major effect; +, minor effect; –, no appreciable effect; ++, moderate effect; N/A, not applicable/tested.